Copyright Reports & Markets. All rights reserved.

Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Research Report 2021

Request for Sample of this report
Buy now

1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Overview

  • 1.1 Product Overview and Scope of Continuous Glucose Monitoring (CGM) Systems for Diabetics
  • 1.2 Continuous Glucose Monitoring (CGM) Systems for Diabetics Segment by Type
    • 1.2.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Wearable
    • 1.2.3 Implantable
  • 1.3 Continuous Glucose Monitoring (CGM) Systems for Diabetics Segment by Application
    • 1.3.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals & Clinics
    • 1.3.3 Homecare Settings
  • 1.4 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size Estimates and Forecasts
    • 1.4.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue 2016-2027
    • 1.4.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales 2016-2027
    • 1.4.3 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size by Region: 2016 Versus 2021 Versus 2027

2 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Competition by Manufacturers

  • 2.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Continuous Glucose Monitoring (CGM) Systems for Diabetics Manufacturing Sites, Area Served, Product Type
  • 2.5 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Competitive Situation and Trends
    • 2.5.1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Continuous Glucose Monitoring (CGM) Systems for Diabetics Players Market Share by Revenue
    • 2.5.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Continuous Glucose Monitoring (CGM) Systems for Diabetics Retrospective Market Scenario by Region

  • 3.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Facts & Figures by Country
    • 3.3.1 North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country
    • 3.3.2 North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Facts & Figures by Country
    • 3.4.1 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country
    • 3.4.2 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Region
    • 3.5.2 Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Facts & Figures by Country
    • 3.6.1 Latin America Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country
    • 3.6.2 Latin America Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country
    • 3.7.2 Middle East and Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Historic Market Analysis by Type

  • 4.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Type (2016-2021)
  • 4.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Type (2016-2021)
  • 4.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Price by Type (2016-2021)

5 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Historic Market Analysis by Application

  • 5.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Application (2016-2021)
  • 5.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Application (2016-2021)
  • 5.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Abbott Diabetes Care Inc.
    • 6.1.1 Abbott Diabetes Care Inc. Corporation Information
    • 6.1.2 Abbott Diabetes Care Inc. Description and Business Overview
    • 6.1.3 Abbott Diabetes Care Inc. Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Abbott Diabetes Care Inc. Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Portfolio
    • 6.1.5 Abbott Diabetes Care Inc. Recent Developments/Updates
  • 6.2 Dexcom
    • 6.2.1 Dexcom Corporation Information
    • 6.2.2 Dexcom Description and Business Overview
    • 6.2.3 Dexcom Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Dexcom Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Portfolio
    • 6.2.5 Dexcom Recent Developments/Updates
  • 6.3 Medtronic
    • 6.3.1 Medtronic Corporation Information
    • 6.3.2 Medtronic Description and Business Overview
    • 6.3.3 Medtronic Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Medtronic Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Portfolio
    • 6.3.5 Medtronic Recent Developments/Updates
  • 6.4 Senseonics Holdings
    • 6.4.1 Senseonics Holdings Corporation Information
    • 6.4.2 Senseonics Holdings Description and Business Overview
    • 6.4.3 Senseonics Holdings Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Senseonics Holdings Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Portfolio
    • 6.4.5 Senseonics Holdings Recent Developments/Updates
  • 6.5 GlySens Incorporated
    • 6.5.1 GlySens Incorporated Corporation Information
    • 6.5.2 GlySens Incorporated Description and Business Overview
    • 6.5.3 GlySens Incorporated Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 GlySens Incorporated Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Portfolio
    • 6.5.5 GlySens Incorporated Recent Developments/Updates
  • 6.6 Meiqi Medical Equipment
    • 6.6.1 Meiqi Medical Equipment Corporation Information
    • 6.6.2 Meiqi Medical Equipment Description and Business Overview
    • 6.6.3 Meiqi Medical Equipment Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Meiqi Medical Equipment Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Portfolio
    • 6.6.5 Meiqi Medical Equipment Recent Developments/Updates
  • 6.7 San Meditech
    • 6.6.1 San Meditech Corporation Information
    • 6.6.2 San Meditech Description and Business Overview
    • 6.6.3 San Meditech Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 San Meditech Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Portfolio
    • 6.7.5 San Meditech Recent Developments/Updates

7 Continuous Glucose Monitoring (CGM) Systems for Diabetics Manufacturing Cost Analysis

  • 7.1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Continuous Glucose Monitoring (CGM) Systems for Diabetics
  • 7.4 Continuous Glucose Monitoring (CGM) Systems for Diabetics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Continuous Glucose Monitoring (CGM) Systems for Diabetics Distributors List
  • 8.3 Continuous Glucose Monitoring (CGM) Systems for Diabetics Customers

9 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Dynamics

  • 9.1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Industry Trends
  • 9.2 Continuous Glucose Monitoring (CGM) Systems for Diabetics Growth Drivers
  • 9.3 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Challenges
  • 9.4 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Restraints

10 Global Market Forecast

  • 10.1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Continuous Glucose Monitoring (CGM) Systems for Diabetics by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Continuous Glucose Monitoring (CGM) Systems for Diabetics by Type (2022-2027)
  • 10.2 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Continuous Glucose Monitoring (CGM) Systems for Diabetics by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Continuous Glucose Monitoring (CGM) Systems for Diabetics by Application (2022-2027)
  • 10.3 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Continuous Glucose Monitoring (CGM) Systems for Diabetics by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Continuous Glucose Monitoring (CGM) Systems for Diabetics by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Wearable
    Implantable

    Segment by Application
    Hospitals & Clinics
    Homecare Settings

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Abbott Diabetes Care Inc.
    Dexcom
    Medtronic
    Senseonics Holdings
    GlySens Incorporated
    Meiqi Medical Equipment
    San Meditech

    Buy now